4
Changes in Ownership
Protara Therapeutics, Inc. Filed Acc 0001209191-20-003243
Director acquired 26,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Braunstein Scott Director | 2020-01-10 | Grant or award | +26,500 | 26,500 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Braunstein Scott Director | 2020-01-09 | Grant or award · Stock Option (Right to Buy) | +9,537 | 9,537 | D: show line 2 in the form | ||
| Braunstein Scott Director | 2020-01-09 | Grant or award · Stock Option (Right to Buy) | +2,861 | 2,861 | D: show line 3 in the form | ||
| Braunstein Scott Director | 2020-01-09 | Grant or award · Stock Option (Right to Buy) | +9,537 | 9,537 | D: show line 4 in the form | ||
| Braunstein Scott Director | 2020-01-09 | Grant or award · Stock Option (Right to Buy) | +6,676 | 6,676 | D: show line 5 in the form | ||
| Braunstein Scott Director | 2020-01-09 | Grant or award · Stock Option (Right to Buy) | +15,737 | 15,737 | D: show line 6 in the form |
Loading xslF345X03/doc4.xml…